Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Don't get rid of mercury yet, says AHA (American Heart Association)

This article was originally published in Clinica

Executive Summary

Replacing mercury sphygmomanometers with more modern aneroid or electronic instruments is not necessarily a good idea, according to an advisory statement by the American Heart Association's Council for High Blood Pressure Research. The newer types of instrument have a number of drawbacks compared with the "gold standard" mercury gravity sphygmomanometer, the Council says in the journal, Hypertension (February).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel